Wellfully Ltd
ASX:WFL
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Wellfully Ltd
Total Liabilities & Equity
Wellfully Ltd
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wellfully Ltd
ASX:WFL
|
Total Liabilities & Equity
AU$3.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Total Liabilities & Equity
AU$1.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Total Liabilities & Equity
AU$248m
|
CAGR 3-Years
115%
|
CAGR 5-Years
56%
|
CAGR 10-Years
25%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Total Liabilities & Equity
AU$47.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
78%
|
|
Probiotec Ltd
ASX:PBP
|
Total Liabilities & Equity
AU$231.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Total Liabilities & Equity
AU$76.9m
|
CAGR 3-Years
104%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wellfully Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
3.5m
AUD
Based on the financial report for Dec 31, 2023, Wellfully Ltd's Total Liabilities & Equity amounts to 3.5m AUD.
What is Wellfully Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-4%
Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Wellfully Ltd have been 18% over the past three years , -3% over the past five years , and -4% over the past ten years .